Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials